Tag: nyse:jnj

June 11, 2019

5 Biggest Pharmaceutical Companies

The Investing News Network breaks down the five biggest pharmaceutical companies within the sector by market cap size.
May 29, 2019

Nemaura Notches CE Mark for SugarBEAT

With the CE Mark approval, Nemaura Medical will be able to sell its SugarBEAT device across the European Union.
May 14, 2019

5 Top Pharmaceutical ETFs

A wide range of investors may want to consider pharmaceutical ETFs as a way to stay informed about and invest...
April 18, 2019

Pharma Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
March 6, 2019

FDA Approves Johnson & Johnson’s Nasal Spray Antidepressant

Spravato, which is administered via a nasal spray, is the first FDA-approved antidepressant in over 30 years.
October 24, 2018

Zymeworks Makes First Dermatology Licensing Deal

This is the first joint antibody discovery and development collaboration for Zymeworks and marks the first dermatology-specific partnership for the...
October 16, 2018

Pharmaceutical Update: Q3 2018 in Review

With Q3 behind us and Q4 already in full swing, the Investing News Network is providing a look at some...